From Chaos to Order

How We Streamlined Testing for Monoclonal Gammopathies and Improved Patient Care

Wednesday, July 27
12:45 – 1:45 p.m.
Exhibit Hall Theater 3
Supported by Binding Site


The detection of monoclonal gammopathies is facilitated by the use of several laboratory tests. When these tests are allowed to be ordered separately, disparate ordering practices can delay diagnosis. We describe our experience in creating panel tests to enable guideline compliant testing and share preliminary data on how such changes have standardized and improved patient care.


After attending this session, participants will be able to:

  • Identify the laboratory tests that should be used to diagnose a monoclonal gammopathy.
  • Describe the baseline assessments used to evaluate current ordering practices for the screening and monitoring of monoclonal gammopathy.
  • Describe the benefits of providing test panels that enable guideline compliant testing.


Monique Dodd
Enterprise Clinical Solutions, Rhodes Group


David Grenache
Chief Scientific Officer
TriCore Reference Laboratories

Teofilo Borunda Duque
Clinical Solutions Specialist
Rhodes Group